Hugh Cole is the founder of Jounce Therapeutics. Jounce Therapeutics has raised $56M in total funding. Latest round: Series B. Based in Cambridge, MA.
Hugh Cole was appointed as the chief business officer and head of corporate development at Jounce Therapeutics. He has over 25 years of experience in the biotech industry, covering business development, corporate strategy, R&D, alliance management, commercial planning and execution, and corporate leadership.
Full founder directory · Investor directory · Company funding database · Fundraising library